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palavras-chave 
 
Fármacos veterinários, contaminação do solo, organismos não alvo e
ecotoxicologia  
 
resumo 
 
 
A utilização dos compostos de uso veterinário e seus efeitos nos diferentes 
compartimentos ambientais têm sido alvo de grande atenção nos anos 
recentes. 
Produtos medicinais veterinários tais como os antibióticos são utilizados no 
combate aos parasitas e na prevenção de doenças em animais. Esses 
compostos são largamente utilizados como aditivos alimentares na indústria de 
criação de galináceos como aceleradores de crescimento. As conseqüências e 
efeitos ainda não conhecidos desses fármacos no ambiente matéria de estudo 
de muitos trabalhos. 
Os compostos fármacos veterinários podem entrar no ambiente por inúmeras 
formas, incluído a via direta, onde esses compostos são aplicados nas águas 
superficiais tal como nos tratamentos de aquacultura através da lixiviação 
oriunda dos tratamentos e das excretas das excretas dos animais. 
O propósito deste estudo era de avaliar o impacto de dois compostos de uso 
veterinário (nicarbazin e monensin) utilizados como aditivos alimentares na 
indústria de criação de galináceos em organismos não alvos e duas espécies 
de plantas. Ensaios ecotoxicológicos foram realizados para avaliar a toxicidade 
aguda e crônica em minhocas (Eisenia andrei), colêmbolos (Folsomia candida) 
e as duas espécies de plantas (Brassica rapa e Triticum aestivum). As 
medidas analíticas dos químicos no solo estiveram de acordo com as 
concentrações nominais utilizadas. Os resultados obtidos demonstraram que 
não houve efeito significativo na exposição ao nicarbazin a todos os 
organismos testados, enquanto que a exposição ao monensin apresentou uma 
dose-resposta de efeito observado. A sensibilidade das espécies decresceu na 
seguinte ordem: Brassica rapa < Eisenia andrei < Triticum aestivum < Folsomia 
candida, com os valores de EC50 variando entre aproximadamente 10 e 
100mg/kg. Esse estudo demonstrou a importância da utilização de uma bateria 
de testes para avaliar os efeitos ecotoxicológicos, principalmente pela 
utilização de diferentes parâmetros de avaliação de resposta e/ou espécies de 
diferentes níveis tróficos. 
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abstract 
 
The usage of veterinary pharmaceutical (VP) compounds and their effects in 
the different environmental compartments have received a special attention in 
recent years.  
Veterinary medicinal products such as antibiotics are used to combat parasites 
and prevent diseases in the animals. They are widely used as food additives in 
the poultry industry and also in other farm animals to promote growth. The 
unknown consequences of these VPs into the environment are a matter of 
concern and many works have been made to analyze the effects of these 
compounds. 
The VP compounds may enter into the environment via a number of different 
pathways, this include direct via, when it’s applied in the surface waters as in 
the aquaculture treatments by wash-off from topical treatments and the excreta 
of animals.    
The purpose of this study was to examine the direct impact of two veterinary 
pharmaceuticals (nicarbazin and monensin) used in the poultry industry on 
non-target organisms and two plant species. Ecotoxicological tests were used 
to evaluate the acute and chronic toxicity in earthworms (Eisenia andrei), 
collembolans (Folsomia candida) and two species of plants (Brassica rapa and 
Triticum aestivum). Analytical measurements of the chemicals were in good 
agreement with the nominal concentrations used. The results obtained showed 
no effect of nicarbazin for all the tested organisms, while in exposures with 
monensin, there was a dose-response pattern. Species sensitivity decreased in 
the following order: Brassica rapa > Eisenia andrei > Triticum aestivum > 
Folsomia candida, with EC50 ranging between approximately 10 and 
100mg/kg. This study showed the importance of the test battery when 
assessing ecotoxicological effects, mainly by using different endpoints and/or 
species from different trophic levels.   
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I. Introduction and objectives  
 
1.1. Introduction  
In recent years the use of veterinary pharmaceuticals, mainly antibiotics, to prevent 
diseases and to promote growth has been intensified. Despite this, their effects in the 
environment are still mostly unknown and as such it has been a matter of concern and 
scientific research.  
Pharmaceutical compounds are designed either to be highly active and interact with 
receptors in humans and animals or to be toxic for many infectious organisms, including 
bacteria, fungi and parasites (Boxall et al., 2004). Veterinary pharmaceuticals (VPs) are 
physiologically highly active substances used in husbandry for combating parasites, 
prevention and treatment of bacterially transmitted diseases (Tolls, 2001). In addition, 
veterinary antibiotics are used to promote growth and feed efficiency in a range of 
animals (Kim and Carlson, 2006), since disease decreases animal performance in 
livestock production: one of the purposes of the use of antibiotics is to limit progression 
of disease in a population (Kemper, 2007).  
The presence of human and veterinary pharmaceutical compounds in the environment 
has received increased attention in recent years (Kim and Carlson, 2006). During the 
past decade, concern has grown about the adverse effects that the use and disposal of 
pharmaceuticals might potentially have on human and ecological health (Kümmerer 
2003), because once in the environment these compounds can affect other living forms 
and humans. Nicarbazin, lasalocid, monensin, salinomycin and narasin (Fig. 1) are 
some of the most commonly used anticoccidial drugs in the poultry industry and also in 
other farm animals. They are authorized for use under the Additives Directive 
70/524/EC. In addition to their anticoccidial activity, these compounds enhance the 
conversion of feed  
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Figure 1 - Chemical structure of common anticoccidial drugs used in the poultry 
industry (Matabudul et al., 2002, adapted) 
Depending on the country and even region, different combinations of veterinary drugs 
are used in animal feed. Veterinary medicines are used widely in the United Kingdom 
(UK) and are important aids in safeguarding animal health and welfare, helping to 
prevent economic loss, and indirectly, to safeguard the food supply and protect public 
health (Capleton et al., 2006). 
There is a high concern that veterinary pharmaceuticals pose a potential risk for 
consumers and this has resulted in the development of methodologies for the analysis of 
such compounds in food products (Furtula et al., 2005).  
There is a prioritized list for veterinary active ingredients, build according to their 
potential for indirect exposure and toxicity profile (see table 5 in Capleton et al., 2006). 
Among these chemicals we can emphasize antimicrobial compounds (e.g. albendazole, 
amoxicillin) and coccidiostat MFAs (e.g. monensin, salinomycin sodium), whose 
potential to reach the environment is high or unknown, have a high usage and toxicity 
profile classification, hence being to a priority for detailed risk assessment. 
Nicarbazin 
Monensin 
Salinomycin 
Lasalocid 
Narasin 
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These compounds are, among others, present in 962 veterinary medicine products that 
were approved for use in the UK (as of August/September 2004, NOAH, 2004) (Fig. 2). 
  
Figure 2 - Quantities of therapeutic antimicrobials, antiprotozoals, antifungals and 
coccidiostats and antimicrobial growth promoters in tones a.i. sold in the UK in 2004 
(VMD, 2004, adapted). 
These include antimicrobials, coccidiostats, ecto and endo-parasiticides, hormones and 
immunological products. Published sales data for antimicrobial products authorised for 
use as veterinary medicines indicate that during 2003, 456 tones a.i. of therapeutic 
antimicrobials (87–93% of which was used in food producing animals), 241 tones a.i. of 
coccidiostats, 36 tones a.i. of antimicrobial growth promoters, and 2 tones a.i. each of 
therapeutic antiprotozoals and therapeutic antiprotozoals, were sold in the UK (VMD, 
2004). Tetracyclines accounted for about half (46%, 212 tonnes) of therapeutic 
antimicrobials sold, while trimethoprims/sulfonomides, β-lactams, aminoglycosides and 
macrolides accounted for 20% (89 tones), 14% (62 tones), 4.6% (21 tones), and 13% 
(60 tones), respectively. Most of the therapeutic antimicrobials sold (57%, 261 tonnes) 
were authorised specifically for use in pig and poultry species (VMD, 2004). 
The amounts of antibiotics used in one year can only be calculated roughly: in 1999, 
13.288 tones of antibiotics were used in the EU and Switzerland, of which 29% were 
used in veterinary medicine, 6% as growth promoters and 65% were used in human 
medicine (FEDESA, 2001).  
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All these compounds can enter into both the terrestrial and aquatic ecosystems by 
several routes. 
 
1.2. Routes of entry 
The most important routes of entry into the environment are likely to be the direct 
discharges of aquaculture products, the excretion of substances in urine and faeces of 
livestock animals, and the wash-off of topical treatments from livestock animals (Fig. 
3).  
 
Figure 3 - Pathways of veterinary medicines to the environment (Boxall et al., 2002). 
Contributions from the manufacturing and formulation processes are likely low in the 
United States and European Union, where manufacture and formulation are subject to 
tight regulatory controls. Generally these routes of entry are considered less relevant 
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than emissions to surface water and soils from aquaculture and herd treatments, 
respectively (Boxall, 2003). 
Human and Veterinary Pharmaceuticals compounds have been found in groundwater, 
surface water, waste lagoon water, and effluent water from wastewater treatment plants. 
Tolls (2001) had shown that ionophore antibiotics are hydrophobic compared to other 
pharmaceuticals, and one could expect significant concentrations in sediments.    
Large amounts of veterinary medicines, such as antibacterials, antifungals and 
parasiticides from aquaculture and agriculture, may also cause stress in the 
environment, particularly since they can be directly discharged into soils and surface 
waters and do not pass through a water treatment plant first, like human medicines 
(FEDESA, 2001).  
Once in the environment, metabolites from parent VPs may be transported and 
distributed between the major environmental compartments. The concentrations in these 
compartments depend on numerous factors and processes, including how the parent 
compound is released into the environment, how fast it degrades, the half-lives of the 
metabolites, partitioning to sludge, soil and sediment, and subsequent movement to air 
and water (Boxall et al., 2004).  
Examples about the distribution of these compounds in the different environmental 
compartments, according to previous studies, are given here after.   
 
1.2.1. VPs in the soil compartment 
Antibiotics used for veterinary purposes are excreted by animals and end up in soils via 
grazing livestock or manure used as agricultural fertilizer (Jørgensen and Halling-
Sørensen, 2000). Once in the soil, antibiotic efficiency depends on the physical–
chemical properties, prevailing climatic conditions, soil types and a variety of other 
environmental factors (Kemper, 2007).  
Measured concentration of VPs (sulfonamides and trimethoprim) in animal waste or 
manure can be very different, e.g. ranging from 0.11 to 12.4 mg/kg (Haller et al., 2002). 
Residuals of antibiotics (oxytetracycline, tetracycline, chlortetracycline and tylosin) 
extensively used in livestock production have been detected in soil previously fertilized 
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with animal slurry (Hamscher et al., 2002). Kim and Carlson (2006) found an average 
concentration of 198.7mg/kg of tetracycline and 4.6–7.3mg/kg of chlortetracycline at a 
soil depth of 10–20 cm and they concluded that when liquid manure is applied 
repeatedly, antibiotics could enter the environment in significant concentrations and 
accumulate persistent residues in the soil.  
 
1.2.2. VPs in the water compartment 
In recent years, the occurrence and fate of antibiotics in the aquatic environment has 
been subject to many investigations carried out in several countries. More than 30 
antibiotic substances have been found in sewage influent and effluent samples, in 
surface waters and even ground and drinking water. Antibiotics used in animal 
husbandry, their metabolites or degradation products can reach the water compartment 
by leaching and or run-off from the application of manure or slurry to areas used 
agriculturally, or from pasture-reared animals excreting directly on the land (Kemper, 
2007).  
Several studies have detected low levels of medicinal active ingredients in the 
environment. In Germany and the United States, low levels (<1μg/l) of antibiotic 
residues have been detected in surface water samples taken from sites considered 
susceptible to contamination (Hirsch et al., 1999; Kolpin et al., 2002), and only four 
residues were detected in 59 groundwater samples taken from areas with extensive 
livestock breeding (Hirsch et al., 1999).  
Kim and Carlson (2006) performed a study to understand the importance of the 
sediment matrix and the partitioning to water for ionophore antibiotics. The average 
pseudo-partitioning coefficients were calculated using sediment concentrations with 
overlaying water concentrations to help the understanding of ionophore antibiotics 
partitioning characteristics in the environment. This study also indicates that antibiotics 
can significantly accumulate in the sediment, potentially impacting the stream benthic 
biota. Hence, they highlighted that when studying the occurrence of antibiotics in the 
environment it is imperative to include the sediments in the analyses.  
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1.3. Humans and Environment: exposure and health risk. 
The available studies demonstrate that low levels of active ingredients of veterinary 
medicine may enter the wider environment and, hence, there is a potential exposure risk 
for ecosystems and humans to veterinary medicines and residues.  
The inherent risk to humans from direct exposure to veterinary medicine residues in 
food products has been widely assessed (as evidenced by the development and 
application of Maximum Residues Levels), but their potential risk from indirect 
exposure via environment has not yet been adequately established.  
Indirect human exposure to medicine compounds may however occur through the 
consumption of (Capleton et al., 2006):  
 • contaminated groundwater and surface waters; 
 • crops that have taken up veterinary medicine from soils to which contaminated 
manure and/or slurry has been applied;  
 • fish from natural environments (and other edible aquatic fauna) unintentionally 
exposed to VP from aquaculture discharges; 
 • non-target animals that have accumulated veterinary medicine through the food 
chain. 
In addition to contamination risks, the extensive use of veterinary pharmaceuticals is 
supposed to be a daunting public health risk resulting in the emergence and spread of 
resistant bacteria, and also in other human, animal and environmental impairments.  
 
1.4. Bacteria / antimicrobial resistance 
A wide range of antibacterials has been observed in waters and soils and many of these 
persist for some time. It is possible that such exposure will result in the formation of 
resistant microbes, which could pose a serious threat to human and animal health 
(Boxall et al., 2004). 
The UK Government has made clear that this problem is taken seriously and has 
developed a comprehensive strategy to address it so that the effectiveness of 
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antimicrobial products in both humans and animals can be maintained. A key element 
of this strategy is the collection and publication of information on the quantities of 
antimicrobial products sold each year for veterinary use in the UK (VMD, 2004). 
Generally, the most probable path for the infection of humans with antibiotic resistant 
bacteria from animal origin is considered to be the consumption of contaminated food 
products derived from treated animals (Haller et al., 2002).  
 
1.5. Treatments, persistence and biodegradability  
Pharmaceuticals can be removed when treated through physical processes, such as 
sorption or volatilization, biological degradation or chemical reactions (e.g. through 
ozone treatment). Many of the treatment methods, whilst removing the pharmaceuticals, 
may also produce transformation products that are more persistent and mobile than the 
parent compounds, some of which may also have similar or enhanced toxicity. Few 
studies have been performed to assess the environmental impacts of these 
transformation products in the environment (Boxall et al., 2004). Antibiotic metabolites 
can also be transformed back to their parent compound after excretion (Kemper, 2007). 
Then, if intracorporal degradation takes place, it is often preceded in the feces, but if 
antibiotics are not metabolized, recalcitrants persist in the environment (Kümmerer et 
al., 2000).  
From above, the question on whether one should worry about transformation products 
can be raised. Most work so far has focused on the parent compounds. However, it is 
known that transformation products are produced in the environment and in treatment 
processes (Boxall et al., 2004). Pharmaceutical substances may also be degraded by 
biological organisms in treatment systems, water bodies and soils as well as abiotic 
reactions. Generally, these processes reduce the potency of medicines, however, some 
breakdown products have similar toxicity to their parent compounds (Halling-Sörensen 
et al, 2002). Furthermore, degradation varies significantly depending on chemistry, 
biology and climatic conditions. For example, the half-life of the antiparasitic 
ivermectin under winter conditions is six times greater than in the summer and the 
compound degrades faster in sandy soils than in sandy loam soils (Halley et al, 1993). 
In laboratory studies with manure-amended soils, a half-life of 13.5d was estimated for 
monensin, and in comparison to field studies shorter half-lives of 3.8 and 3.3 d were 
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observed in manure-amended and unamended fields, respectively, and no monensin was 
detected below a depth of 25 cm (Carlson and Mabury, 2006). In addition, recent 
studies showed that monensin degrades fairly rapidly under aerobic conditions in 
manure, but degradation is slowed down under anaerobic conditions. Additionally, 
climate changes can accelerate the degradation process too. 
 
1.6. Regulation of veterinary compounds in the world 
The regulation of the veterinary compounds is different according to the country. For 
instance, Health Canada regulates the sales of drugs through the Food and Drugs Act 
and Regulations, and the Controlled Drug and Substance Act. For human drugs, these 
legislations are administered primarily through the Therapeutic Products Directorate 
(TDD). For veterinary drugs, including antimicrobials for food animals, these 
legislations are administered primarily through the Veterinary Drugs Directorate 
(VDD), formerly Bureau of Veterinary Drugs (EIVD). The VDD is responsible for 
human food safety issues pertaining to veterinary drugs. Each province in Canada has 
its own regulatory body. Quebec has more stringent regulations than other provinces. 
The sale of veterinary drugs is restricted to pharmacists and veterinary surgeons. Some 
drugs may only be sold under veterinary prescription, while others may be sold freely. 
Permits are required to manufacture, distribute and sell medicated premixes or 
medicated feeds (VDD 2002).  
In the UK, the Veterinary Medicines Directorate (VMD), an Executive Agency of the 
Department for environment, food and rural affairs (Defra) is responsible for the 
authorization of veterinary medicines (Haller et al., 2002). 
Within the European Union, national and/or EU authorities control the marketing 
authorisation for new veterinary pharmaceutical product to be released and 
commercialised, ensuring its efficacy, quality and safety to public health and 
environment. There are some requirements for ecotoxicity testing that can be found in 
the European legislation by Directive 81/851/EEC, and Directive 81/852/EEC and have 
recently been codified in Directive 2001/82/EC (Koschorreck et al., 2002). The 
European Agency for the Evaluation of Medicinal Products (EMEA) is the entity 
responsible for the coordination of scientific resources in the Member States of the EU 
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in order to evaluate and supervise medicinal products for both human and veterinary 
use.  
Environmental Risk Assessment procedures as part of the authorisation routine for VPs 
or other chemical compounds have identified mitigation measurements that can 
diminish contamination to acceptable levels. 
Several harmonization efforts have been made to improve ERA procedures in terms of 
scientific and regulatory efficacy (Van den Brink et al, 2005). In April 1996 the VICH 
programme (International Cooperation on Harmonisation of Technical Requirements for 
Registration of Veterinary Medicinal Products) was officially launched. This is a 
trilateral (EU-Japan-USA) program aimed at harmonizing technical requirements for 
veterinary product registration. This programme aims to establish and implement 
regulatory requirements for veterinary medicinal products by increasing quality, safety 
and efficacy standards and minimize the use of test animals and costs of product 
development. Another goal of VICH is to ensure efficient processes for maintaining and 
monitoring consistent interpretation of data for the implementation of guidelines. The 
interaction between regulatory authorities and industry can provide technical guidance 
enabling response to significant emerging global issues and science that impact on 
regulatory requirements within the VICH regions (http://www.vichsec.org/).    
 
1.7. Objectives and structure 
The main goal of this study was to determine the impact of two veterinary 
pharmaceuticals (nicarbazin and monensin) used in the poultry industry on non-target 
organisms and two plant species.  
Ecotoxicological tests were used to evaluate the acute and chronic toxicity in 
earthworms (Eisenia andrei), collembolans (Folsomia candida) and two species of 
plants (Brassica rapa and Triticum aestivum).  
This thesis is structured as follows: 
· Chapter I: the actual chapter consists of a general introduction, focusing on 
general applications of veterinary medicine compounds, their potential to reach 
the environment, toxicity profile and classification to human and environmental 
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health, and also regulatory and environmental risk assessment procedures 
worldwide; 
· Chapter II: paper entitled: “Veterinary Pharmaceuticals used as food additives 
in the poultry industry: effect assessment through a soil test battery”  
· Chapter III: general discussion and conclusion. 
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Abstract 
Veterinary pharmaceuticals are widely used as food additives in the poultry industry 
and the unknown consequences of releasing these compounds into the environment are 
a matter of concern. The purpose of this study was to determine the direct impact of two 
veterinary pharmaceuticals (nicarbazin and monensin) used in the poultry industry on 
non-target organisms and two plant species. Ecotoxicological tests were used to 
evaluate the acute and chronic toxicity in earthworms (Eisenia andrei), collembolans 
(Folsomia candida) and two species of plants (Brassica rapa and Triticum aestivum). 
Analytical measurements of the chemicals were in good agreement with the nominal 
concentrations used. The results obtained showed no effect of nicarbazin for all the 
tested organisms, while the exposure to monensin caused a dose-response pattern. 
Species sensitivity decreased in the following rank order: Brassica rapa > Triticum 
aestivum > Eisenia andrei > Folsomia candida, with EC50 ranging between 
approximately 10 and 100mg/kg. This study showed also the importance of using a test 
battery when assessing ecotoxicological effects, mainly by using different endpoints and 
species from different trophic levels.   
 
Keywords: nicarbazin, monensin, soil contamination, soil arthropods, ecotoxicology. 
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Introduction 
 
Veterinary pharmaceuticals (VPs) are physiologically highly active substances used in 
husbandry to combat parasites, prevent and treat bacterially transmitted diseases (Tolls, 
2001). In addition, veterinary antibiotics are used to promote growth and feed efficiency 
of animals in farm activities (Kim and Carlson, 2006). Veterinary compounds enter the 
environment through several pathways, e.g. during the manufacture and formulation 
process and disposal, emissions to surface water and soils from aquaculture and herd 
treatments. Once in the environment, VP may be transported and distributed between 
the major environmental compartments. The concentrations in these compartments 
depends on numerous factors and processes, including how the parent compound is 
released into the environment, how fast it degrades, the half-lives of the compounds, 
partitioning to sludge, soil, and sediment and subsequent movement to air and water 
(Boxall et al., 2004). All these have increased the concern about the adverse and 
potential effects of pharmaceuticals on human and ecological health (Kümmerer, 2003). 
It is known that once in the environment, these VP compounds can affect several living 
forms. Nicarbazin and monensin are two of the most common anticoccidial drugs used 
in the poultry industry and also in other farm animals, and their use is authorized by the 
Additives Directive 70/524/EC. In addition to their anticoccidial activity, these 
compounds enhance the conversion of food to weight gain in the animals raised on 
medicated feeds (Matabudul, 2002). Nicarbazin is a carbanilide compound also used as 
a inhibitor of egg hatching in the geese Branta canadensis by interfering in the 
formation of the vitelline membrane, separating the egg yolk and egg white (EPA 
factsheet for Nicarbazin).  
The main goal of this study was to determine the impact of these veterinary 
pharmaceuticals in the terrestrial environment, using a battery of standardized toxicity 
tests to assess toxicity in soil, and in which different trophic levels were assessed using 
plants, earthworms and collembolans. 
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Materials and Methods 
 
Test species 
 Earthworms 
Eisenia andrei (Oligochaeta) was used as test species in acute toxicity tests. They were 
maintained in culture laboratory in a moist substrate (50% horse manure, 50% peat) at 
20±2ºC, and a 16:8h light:dark cycle (OECD 1984). Organisms between 300-600mg, 
with well developed clitellum, were selected and acclimatized for 24h in the test soil 
(with no contamination) prior to the experiment. 
 
 Collembolans 
Folsomia candida (Collembola), a blind, unpigmented, euedaphic collembolan 
reproducing parthenogenetically (Hopkin 1997) was used in the reproduction bioassay. 
Organisms were kept in culture in a moist substrate of plaster of Paris and activated 
charcoal, at 18ºC, in the dark, being weekly fed with dried baker’s yeast 
(Saccharomyces cerevisae) (ISO, 1999). Synchronized cultures were established prior 
to the start of the test, to use organisms within the same age interval (between 10-12 
days old).  
 
 Plants 
Two plant species, the monocotyledonous Triticum aestivum and a dicotyledonous 
Brassica rapa, were used in a seedling and growth test based on the species list 
available in the ISO guideline 11269-2 (1995). Seeds of Brassica rapa were purchased 
from Carolina Biological Supply Company (US) and Triticum aestivum in a local 
supplier (Aveiro, Portugal). 
 
Test substances 
Nicarbazin (C19H18N6O6, Sigma Aldrich) is a complex of two compounds, 4,4’-
dinitrocarbanilide (DNC, M=302.25 g/mol) and 4,6-dimethyl-2-pyrimidinol (HDP, 
M=124.14 g/mol), being DNC considered the active component, while HDP aids in 
absorption. Monensin (C36H61O11Na, M=692,9 g/mol, 90-95% purity by thin-layer 
chromatographic (TLC) Sigma Aldrich) is a sodium salt of a polyether monocarboxylic 
acid produced by Streptomyces cinnamonensis. 
 24 
 
 
Test soil 
All tests were performed with the natural standard soil LUFA 2.2 from Speyer, 
Germany (Lokke and Van Gestel, 1998). The main characteristics of the test soil are 
presented in Table 1.   
 
Table 1 - Main pedological characteristics of the LUFA 2.2 soil, showing values of pH, 
organic matter content (OM), Carbon/Nitrogen ratio (C/N), grain size distribution, 
cation exchange capacity (CEC) and water holding capacity (WHC). 
Soil pH (CaCl2) 
OM 
(%) C/N 
Clay 
(%) 
Silt 
(%) 
Sand 
(%) 
CEC 
(cmol/kg) 
WHC 
(%) 
LUFA 2.2 5.8 4.4 14.0 6.0 17.0 77.0 11.2 55.0 
 
The contamination of the test soil with nicarbazin was carried out directly into the soil 
as powder due to its insolubility. Contamination with monensin was done by mixing 
solvent solutions of the chemical into the pre-moistened soil, each test concentration 
into the whole batch of soil for all replicates. After homogeneous mixing, subsamples of 
the batch of soil were introduced into the test vessels. In addition, a control solvent 
(acetone) was prepared when testing monensin. Details from the experimental setup and 
concentration range are presented in table 2.   
 
Table 2 - Summary of tests performed, showing details about chemical application and 
concentration range used. DW: Dry Weight; a.i.: active ingredient. 
Compound Test specie Chemical Application 
Concentration range 
(mg a.i./kg soil DW) 
Nicarbazin 
Eisenia andrei directly 10-100-1000 
Folsomia candida directly 10-32-100-320-1000 
Triticum aestivum directly 1- 3.2-10-32-100-320-1000 
Brassica rapa directly 1- 3.2-10-32-100-320-1000 
Monensin 
Eisenia andrei solution 3.2-10-32-100-320 
Folsomia candida solution 10-32-100-320-1000 
Brassica rapa solution 1- 3.2-10-32-100-320 
Triticum aestivum solution 1- 3.2-10-32-100-320 
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Test procedures 
 
Earthworms 
Test procedures followed the standard OECD earthworm acute toxicity test (OECD, 
1984). Ten adult worms with well-developed clitellum, weighting 300-600mg, were 
introduced in a glass vessel, containing 500g of test soil each, moistened to 40-60% of 
the maximum WHC. Water was replenished weekly based on weight loss. Four 
replicates per treatment were used. The test duration was of two weeks. Test run at 
20ºC, with a 16h:8h (light:dark) photoperiod. At the end of the test, organisms were 
counted and weighed. The endpoints were survival (monitored at days 7 and 14) and 
loss of biomass (day 14). Earthworms growth ratio (GR) was calculated using the 
following equation:  
GR= (final weight - initial weight) / initial weight 
 
Collembolans 
 Test procedures were as described in the ISO guideline 11267 for F. candida. Ten 
organisms with 10 to 12 days old were used per test container, which already contained 
the test soil plus food supply. Four replicates per treatment were used. Vessels were 
covered with a parafilm layer in which a few holes for aeration were made. Food (2 mg 
of granulated dry yeast) was added at the beginning of the test and at day 14. Water was 
added weekly based on weight loss. Tests ended after four weeks, the test ended, and 
each test vessel was filled with distilled water, gently stirred with a spatula, causing 
floatation of the organisms. Through digital imaging and using special software 
SigmaScan Pro 5 (SPSS, 1999), organisms were automatically counted. Adults and 
juveniles were easily distinguished by their size. 
 
Plants 
The methodology used to evaluate the toxicity of VPs to plants followed the standard 
protocol ISO 11269-2 (ISO 1995). The test duration was 14 days after 50% of seeds had 
emerged in the control soil. Four replicates per treatments were used. Each replicate is a 
plastic pot with 400 ± 50 g of soil, where 10 seeds were placed at a maximum depth of 1 
cm from the soil surface. A fibreglass wick (between 5-10 mm Ø) was located at the 
pot’s bottom, where a hole was previously made (Loureiro et al. 2006). The pot was 
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then placed on a smaller pot with water so that moisture maintenance could be done by 
capillary action through the fiberglass wick. Bioassays were carried out at 20 ± 3ºC, 
with an illumination of 10000 lux, in a 14:10h light:dark photoperiod. In the first 7 
days, seeds’ germination time was reported. At test end, growth (shoot length), fresh 
and dry weight were recorded. The hydric content ((DW-FW)/DW*100) was calculated 
at day 14 and compared within treatments. 
 
Soil analysis 
Compounds were analyzed by liquid chromatography coupled with electrospray 
ionization mass spectrometry (LC-API-ES-MS) and confirmed by LC-MS-MS 
technique. 
 
Statistics 
One way analyses of variance (ANOVA), followed by Dunnett’s test, was used to 
analyse differences between control and treatments (SPSS, 1997). Whenever data were 
not normally distributed and data transformation did not correct for normality, a 
Kruskal–Wallis ANOVA on Ranks was performed (Zar, 1996), followed by the Dunn's 
method when significant differences were found. Differences between control and 
control solvent were analysed using a t-test (SPSS, 1997). EC50 values were calculated 
using a sigmoidal (logistic, 3 parameter) equation (SPSS, 1997). LC50 values were 
calculated through Probit (SPSS, 2003). 
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Results  
 
Eisenia andrei 
Results of the exposure of Eisenia andrei to nicarbazin and monensin can be observed 
in figure 4.  
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Figure 4 - Effect of nicarbazin and monensin in Eisenia andrei acute bioassay, in terms 
of growth ratio.  
Results are shown as growth ratio, calculated using the following equation:  
GR=(Wf-Wi)/Wi where GR is the growth ratio, Wi is the initial weight and Wf is the 
final weight.  
For nicarbazin, no effect on survival could be observed (one dead worm in the highest 
concentration in one single replicate). In terms of biomass loss, there was no significant 
differences between the control and treatments (ANOVA, F3,15 = 0,074; p = 0,973).  
For monensin, there was no effect of the solvent used (t test, p>0.05). Monensin caused 
an effect on the worms’ survival (LC50=42.7mg/kg) (Tab. 2) and in terms of biomass, 
showed as growth rates, there was a stimuli in the organisms exposed to the 
concentration of 10mg/kg, showing an increase of approximately 20% when compared 
with the control group. The EC50 value was not possible to calculate.  
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Folsomia candida 
Results of the exposure of Folsomia candida to nicarbazin and monensin can be 
observed in the following figure (Fig. 5). 
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Figure 5 - Effect of nicarbazin and monensin in Folsomia candida chronic bioassay, in 
terms of survival (number of adults) and reproduction (number of juveniles). Results are 
expressed as average plus standard error. *- Dunnett’s test, p≤0.05, for juveniles 
production; **- Dunnett’s test, p≤0.05, for adult’s survival.  
 
Nicarbazin caused no effect on survival and reproduction of the organisms (ANOVA, 
p>0.05). 
When testing monensin, there was no effect between the control and the control solvent 
(t-test, p>0.05). There was a dose-response pattern at the reproduction level, with 
significant effects between control and the concentrations of 100, 320 and 1000mg/kg 
(ANOVA, Dunnett’s method, p≤0,05) and the EC50 value obtained was of 100.6 mg/kg.. 
For adults, significant difference was observed only between control and the highest 
concentration (ANOVA, Dunnett, p≤0,05). 
 
Plants 
Results of the exposure to nicarbazin and monensin of Brassica rapa and Triticum 
aestivum can be observed in figures 6 and 7. 
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Figure 6 - Effect of nicarbazin on plant length, fresh weight (FW) and dry weight (DW) 
of Brassica rapa and Triticum aestivum. Results are expressed as average plus and 
minus standard error. *- Dunn’s Method, p≤0.05. 
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Figure 7 - Effect of monensin on plant length, fresh weight (FW) and dry weight (DW) 
of Brassica rapa and Triticum aestivum. Results are expressed as average plus and 
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minus standard error. *: Dunnett’s test, p ≤0.05; Cts- control solvent and **: t-test, p 
≤0.05. 
For nicarbazin, no dose response effect could be observed in both plant species, 
(ANOVA, p >0.05). 
When testing monensin, there was a significant effect caused by the solvent for 
Brassica rapa (t-test, p ≤0,05) while no effect was observed in Triticum aestivum (t-test, 
p>0.05). A dose-response could be observed for both tested plants. EC50, NOEC and 
LOEC values are presented in Table 2. For Brassica rapa, significant differences were 
observed for all measured endpoints, between the control and the test concentrations of 
10, 32, 100 and 320 mg/kg (ANOVA, Dunn’s Method, p≤0.05). For Triticum aestivum, 
significant differences occurred between control and the test concentrations of 32, 100 
and 320mg/kg, except for dry weight, where there was a significant stimuli at 3.2mg/kg 
and a significant decrease at 100 and 320mg/kg (ANOVA, Dunnett’s Method, p≤0,05). 
The percentage of water retained in plants of T. aestivum exposed to monensin was 
significantly higher in the control when compared with the highest treatments (32, 100 
and 320 mg/Kg) (Dunn's Method, p≤0.05). In the B. rapa experiment, this effect was 
even more pronounced with all concentrations inducing a significant decrease in the 
hydric content, with the exception of the lowest one (Dunn’s Method, p ≤0.05). 
Table 3 - Toxicological values calculated for the different test species and endpoints 
when exposed to monensin: EC50, LC50, LOEC and NOEC obtained for all tests 
performed. n.d.: not determined.  
Test species EC50 / LC50 (mg/kg) 
LOEC 
(mg/kg) 
NOEC 
(mg/kg) 
Eisenia andrei 
Biomass n.d. 32 100 
Survival 42.7 32 n.d. 
Folsomia candida 
Juveniles 100.6 100 32 
Adults 1261.8 1000 320 
Brassica rapa 
Plant length 32.8 32 10 
Fresh weight 11.8 32 10 
Dry weight 15.2 32 10 
Triticum aestivum 
Plant length 135.0 32 10 
Fresh weight 40.3 32 10 
Dry weight 99.9 100 32 
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Soil 
The actual chemical analysis of nicarbazin in soil showed a recovery varying from 63 to 
93% of nominal values (Table 4), meaning that this chemical is very stable in soil and 
that the concentrations were maintained throughout the test periods. So, all calculations 
were based on nominal concentrations. 
 
Table 4: Analitical soil data resulting from chemistry analysis of nicarbazin in soil, 
showing the nominal and measured concentrations at the test ends.  
Nominal 
concentration 
in soil 
(mg/kg) 
Measured 
concentration 
at day 0 
(mg/kg) 
Recovery 
(%) 
Measured 
concentration at 
test end (mg/kg) 
Average 
stability of 
Nicarbazin 
in soil in 
the end of 
the test 
(%) 
 
Eisenia andrei (14 days) 
10 6.73 67 6.83  101  
100 101.7 102 99.3  98  
1000 762.3 76 815.8 107  
Folsomia candida (28 days) 
10 8.83 88 6.49 73  
32 20.1 63 21.5 107  
100 95.2 95 95.7 101  
320 299.2 94 264.8 89  
1000 766 77 743.4 97  
Triticum aestivum & Brassica rapa (14 days) 
1 0.89 89 T. aestivum 0.59 
B. rapa 
1.33 108  
3.2 2.77 87 2.36 2.21 82  
10 8.83 88 7.93 7.99 90  
32 20.1 63 25.1 20.55 114  
100 95.2 95 86.8 57.5 76  
320 299.2 94 320.5 320.5 99  
1000 776 78 808.3 808.3 104  
 
Discussion  
The overall results with the VP nicarbazin showed that this compound causes no 
harmful effect to the tested soil organisms and plants, within a broad range of 
concentrations. Additionally, the average concentration found in field soil is around 10-
20 mg/kg (Furtula et al., 2005), a much lower dose than the ones tested here. Therefore 
this chemical is unlikely to pose immediate concern. The low toxicity may be related 
with its low solubility and bioavailability as pure compound. Analyses made in this 
study to determine the presence of nicarbazin in soil detected that four weeks after 
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application in the soil the concentrations measured varied from 63% to 95% of the 
nominal values.  
Contrastly, the other VP tested, monensin, caused a much higher effect on the tested 
species. In Eisenia andrei there was a high effect on survival. Nevertheless, biomass 
changes were not statistically significant at nonlethal concentrations and there was even 
a growth stimuli at 10mg/kg. Further studies should include the assessment of effects at 
the reproduction level. In Folsomia candida there was a very low effect on adults 
(LC50>1000mg/kg) but the reproduction was highly affected. In plants, both test species 
were affected, showing a dose-response pattern, with B. rapa being more sensitive than 
T. aestivum. An interesting fact was the stimuli caused by the solvent acetone in both 
species, which is in accordance with evidences showed in previous studies. In fact, 
Bhattacharya and coauthors (1985) showed that acetone, among other solvents (e.g. 
ethanol and methanol), had an enhanced effect on root formation on etiolated hypocotyl 
cuttings of Vigna radiate; In another study with wheat, onion, garlic, and cabbage, low 
acetone concentrations increased the ability of callusing and meristem formation, as 
well as the capacity to regenerate (Vnuchkova et al., 1993).  
In the exposure to monensin it was observed that this VP induces changes in the 
osmotic regulation of plants. The hydric content was affected by monensin even at low 
concentrations. However, monensin seems to be of little concern to the environment: in 
a study where 5 sites were analyzed (with two in areas of great impact of urban and 
agricultural activities), the highest concentration found in the soil was 31,5μg 
monensin/kg (Kim and Carlson, 2006), which is much lower than the concentrations 
used in this study. Similarly, studies with other veterinary pharmaceutical compounds 
(e.g. tylosin, oxytetracycline) demonstrate that the effect concentrations for soil fauna 
are normally higher than the ones found in the environment. Baguer and coauthors 
(2000) showed that the concentration effect for reproduction of Folsomia fimetaria and 
Aporrectodea caliginosa exposed to tylosin was 5000mg/kg and 4000mg/kg 
respectively, and no effect was observed in the exposure to oxytetracycline for both 
species in the same concentrations range. 
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Conclusion 
 
The effect of veterinary pharmaceuticals depends greatly on the chemical compound, 
varying from a no effect scenario (nicarbazin) to a higher effect (monensin). For 
monensin, species sensitivity decreased in the following order: Brassica rapa > 
Triticum aestivum > Eisenia andrei > Folsomia candida, with EC50s ranging between 
approximately 10 and 100mg/kg. Nevertheless, neither nicarbazin nor monensin showed 
to be causing an ecological risk.   
From the EC50, LOEC and NOEC values one can conclude that single species tests by 
their own are not sufficient to evaluate properly the potential ecotoxicity of chemical 
compounds. In addition, several endpoints showed also dissimilar sensitivities towards 
exposures. This might be due to the fact that chemical compounds can act in specific 
targets that are later traduced in specific changes. If the endpoint studied is not related to 
the target, it can lead to wrong assumptions. Hence, the use of a test battery and higher 
effect levels when assessing chemicals in the environment is highly desirable and 
recommended.   
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Discussion 
Generally, the impact of antimicrobial drugs administered to animals in the different 
environmental compartments have many dependent variables such as the amount of 
chemicals used, type of administration, animal husbandry practices, animal metabolism, 
manure handling and storage and degradation rates (Kemper, 2007).  
Many studies are being developed worldwide to study the behaviour and toxicity of 
these compounds in the environment and their inherent consequences to the soil fauna 
and flora. 
In studies reported by Baguer et al., (2000), two veterinary pharmaceuticals (tylosin and 
oxytetracycline) showed a low toxicity to soil dwelling fauna, with EC10 values around 
150mg/kg. The highest concentration of monensin found in the soil in another study 
carried by Kim and Carlson (2006) was 31,5μg monensin/kg. These results as well as 
the ones obtained in this work showed that the effect concentrations are higher than the 
ones usually found in the environment.  
The overall results presented in this study with the VP nicarbazin showed that this 
compound causes no harm to the tested soil organisms and plants, within a broad range 
of concentrations. Additionally, the average concentration found in the field is around 
10-20 mg/kg of soil (Furtula et al., 2005), a much lower dose than the ones tested here. 
Therefore this chemical poses also no immediate concern. However, this compound is 
very stable and four weeks after its application in soil the concentrations measured 
varied from 63 to 95% of the nominal initial values. This confirms that nicarbazin is 
quite persistent and may have some impact on terrestrial and aquatic ecosystems in 
longer-term periods. 
Dolliver et al., (2008) studied the degradation of three antibiotics (chlortetracycline, 
monensin and tylosin) during manure composting during a period of 22-35 days. For 
chlortetracycline it was observed a reduction on its concentration of 99%, whereas for 
monensin and tylosin the observed reduction ranged from 54 to 76%. The half-lives for 
chlortetracycline, monensin, and tylosin were 1, 17, and 19 d, respectively. Other 
studies carried out by Carlson and Mabury (2006) detected half-lives of 4.5, 24, and 3.3 
days with the addition of manure, and of 6.1, 21, and 3.8 days without manure for 
tylosin, chlortetracycline and monensin respectively. All these compounds were not 
highly mobile with the exception of chlortetracycline that was the only antibiotic 
founded at 25 to 35 cm depth. 
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The long-term dispersion of liquid manure on fields may create serious problems of 
contamination, mainly when these compounds have a potential to accumulate in the soil 
and be biomagnified throughout food chains (Kemper, 2007).   
In addition, another matter of concern is the exposure of bacteria to repeated dosages of 
these compounds. The long-term and repeated exposure can cause an adaptation to the 
presence of VP and increase resistance (Gavalchin and Katz, 1994). This might lead in 
the future to an increase in dosages or to the creation of other compounds with higher 
toxicity, due to the development of resistance mechanisms in the bacteria, as already 
reported for other medicines.  
Further research should be conducted using these VP compounds as a formulation, for 
better simulating real scenarios.  
Conclusion 
The overall results of this study showed that the veterinary pharmaceutical nicarbazin 
causes no harmful effect to the plants Brassica rapa and Triticium aestivum as well as 
to soil organisms (Eisenia andrei and Folsomia candida), within a wide range of 
concentrations. Contrastly, for monensin a dose-response pattern was found but the 
concentrations that impaired the tested organisms are higher than the ones that can be 
found in real scenarios in soils. 
As previously described, in the discussion of the results, other studies carried out with 
VP compounds have demonstrated similar results concerning the usual concentrations 
found in the environment, which are much lower than the concentration ranges used in 
the laboratory to obtain a dose-response of the compounds.   
Usually, ecotoxicity studies use VPs as pure compounds for their exposure assessment, 
and this has been sometimes difficult due to the lower solubility of these compounds. 
Hence, formulations should also be assessed because they will make easier the 
adsorption of the compound to the soil particles and organic matter, and will also make 
possible its incorporation in the soil interstitial water. This will better simulate real 
scenarios and as such deserves further research. 
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